Xinyuan shares: it is proposed to launch the restricted stock incentive plan in 2022

Synthetic Biology: Who Will Emerge as the Winner?

The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.

Apple Intelligence China Beta Due Later in October, with Alibaba’s Qwen Integration

Apple（苹果）plans to release a test version of Apple Intelligence in mainland China later in October, incorporating capabilities from Alibaba’s Qwen（千问）model family. The rollout would bring selected AI features to Chinese users while giving Alibaba a distribution channel within Apple’s device ecosystem.

Transsion Holdings Debuts in Hong Kong, Completing A+H Dual Listing

Shenzhen Transsion Holdings（传音控股）, the Chinese handset maker behind TECNO, itel and Infinix, began trading on the Hong Kong Stock Exchange on October 15, completing an A+H dual listing and adding an offshore equity-financing channel to support its emerging-market business.

Building the Data Infrastructure for Physical AI: Hesai Launches Kosmo 3D World Data Engine

Hesai Group (Nasdaq: HSAI; HKEX: 2525) ("Hesai" or the "Company"), a Physical AI infrastructure company, today launched Kosmo, a 3D world data engine built to solve one of the most critical bottlenecks in Physical AI: access to high-quality real-world data at scale.

Bloomage: Injecting Biotechnology into Beauty Care

Listed on the Chinese Star Market in November 2019, Bloomage was trading at CNY 138.01 as of June 24, 2020, over 38% higher than the IPO price of CNY 100.